Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-25 Purchase | 2024-07-29 4:18 pm | Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director | 4,000 | $1.82 | $7,280 | 6,740 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-20 Option Award | 2024-05-21 4:22 pm | N/A 2034-05-19 | Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-17 5:16 pm | N/A 2034-05-15 | Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:40 pm | N/A 2033-08-09 | Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-13 4:47 pm | N/A 2033-06-12 | Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:24 pm | N/A 2032-06-09 | Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:40 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 4:38 pm | N/A 2030-06-16 | Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director | 23,250 | $0 | 23,250 (Direct) | View |